Startup profile for Isara Laboratories: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Isara Laboratories funding, valuation and investors

San Francisco startup building infrastructure for coordinating thousands of AI agents on complex analytical tasks.

Keep track of Isara Laboratories

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series A

$94M · March 2026

Latest known valuation

$650M

Series A · March 2026

Total disclosed equity funding

$94M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series a · San Francisco, California

Investors in latest funding

Lead: OpenAI

Other: Amity Ventures , Michael Ovitz , Stanley Druckenmiller

Sources: latest funding Last verified: 2026-07-25

Overview

Isara Laboratories is a San Francisco AI startup building orchestration software for large-scale multi-agent systems — enabling thousands of specialized agents to communicate, divide tasks, and synthesize outputs on problems no single model handles alone. Founded in June 2025 by Eddie Zhang (former OpenAI AI safety researcher, MIT visiting researcher) and Henry Gasztowtt (Oxford computer science), the company raised $94 million in March 2026 at a $650 million valuation with OpenAI among investors alongside Amity Ventures, Michael Ovitz, and Stanley Druckenmiller. Isara has no commercial product in market yet but demonstrated ~2,000 agents coordinating on gold-price forecasting. Engineering is based in London, commercial teams in New York, and research in Romania. Initial target customers are investment firms; biotech and geopolitical analysis are secondary markets.

Why Isara Laboratories is interesting

Founded by two 23-year-olds nine months before a $94M round at $650M valuation with OpenAI participating — pre-product, but demoed ~2,000 agents forecasting gold prices.

Product & use cases

Isara builds multi-agent swarm orchestration infrastructure — runtime and coordination layers letting hundreds or thousands of specialized agents align goals, exchange data, and produce combined analytical outputs. Early demo: ~2,000 agents forecasting gold prices.

  • Investment firms running predictive modeling with coordinated agent swarms
  • Biotech research dividing complex multi-step analytical workflows across agents
  • Geopolitical and macroeconomic trend analysis requiring parallel specialized reasoning
  • Enterprise workflows where single-model prompts fail on multi-domain complexity

Key facts

  • Series A (March 2026): $94M at $650M valuation — The Next Web / WSJ reporting
  • OpenAI participated; co-founder Eddie Zhang is former OpenAI AI safety researcher
  • ~12 researchers hired from Google, Meta, and OpenAI
  • Demo: ~2,000 agents coordinating on gold-price forecast at private conference
  • Offices: engineering in London, commercial in New York (515 W 20th St lease), research in Romania

Funding history (newest first)

Series A

2026-03 $94M Valuation: $650M
  • OpenAI (lead)
  • Amity Ventures (participant)
  • Michael Ovitz (participant)
  • Stanley Druckenmiller (participant)

Source: https://thenextweb.com/news/openai-isara-ai-agent-swarms-650m-valuation

Competitive landscape

Edge: Ambition to coordinate agent swarms at thousands-agent scale — beyond LangChain/CrewAI single-or-few-agent frameworks — backed by OpenAI strategic investment and researchers from Google, Meta, and OpenAI.

Multi-agent AI is moving from demos to enterprise pilots, but most frameworks handle handfuls of agents. Isara's $94M pre-product raise bets swarm coordination becomes a distinct infrastructure layer — similar to how data infrastructure companies preceded the LLM wave. Execution and first commercial deployments will determine whether the valuation holds.

  • LangChain / LangGraph adjacent

    Popular open-source agent framework; Isara targets larger-scale swarm coordination rather than developer tooling.

  • CrewAI adjacent

    Multi-agent orchestration framework; Isara aims for orders-of-magnitude more agents with production-grade reliability.

  • Microsoft Copilot Studio incumbent

    Enterprise agent builder within Microsoft ecosystem; less focused on research-grade swarm coordination.

  • OpenAI (internal agents) adjacent

    OpenAI invested in Isara for strategic optionality — potential overlap if OpenAI builds native multi-agent infrastructure.

Notable stories

  • Zhang and Gasztowtt co-authored an ICML 2024 paper on AI systems cooperating to improve policymaking — the intellectual foundation for Isara's swarm architecture (VKTR, March 2026).
  • OpenAI investing $94M in a startup founded by its own former safety researcher reflects the industry's 'acqui-hire-or-invest' pattern to retain exposure to departing talent building adjacent capabilities.

Industries

AI & Machine Learning Enterprise SaaS

Related funding articles

Venture Capital Tracker pieces that cover Isara Laboratories's financing or category context.

FAQs about Isara Laboratories

Practical answers founders, operators, and investors typically search for.

Isara builds software infrastructure for coordinating thousands of AI agents on complex analytical tasks — swarms that divide work, share data, and synthesize outputs together.
Isara raised $94 million in March 2026 at a $650 million valuation. Some roundups cited ~€81M equivalent; primary reporting confirms $94M.
Eddie Zhang (former OpenAI AI safety researcher) and Henry Gasztowtt (Oxford CS) — both 23 at founding in June 2025.
Yes — OpenAI participated in the March 2026 round; Zhang previously worked on AI safety at OpenAI.
No commercial product in market as of March 2026 — the company demonstrated ~2,000 agents forecasting gold prices as a proof of concept.
LangChain provides developer frameworks for building agents; Isara targets production-scale swarms of thousands of coordinating agents on enterprise analytical problems.
Investment firms first for predictive modeling; biotech and geopolitical analysis are planned secondary markets.
San Francisco HQ; engineering in London, commercial team in New York, research hub in Romania.
Pre-revenue — founded mid-2025, raised $94M before commercial launch.
Series A at $650M valuation — March 2026.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.